2013 American Transplant Congress
Early Indicators of Kidney Graft Injury Mediated by Class II Donor Specific Antibodies (DSAII)
Introduction. Pre-transplant DSAII is associated with chronic antibody mediated rejection/transplant glomerulopathy (TG) and high risk of graft loss (GL). However, not all DSAII result in…2013 American Transplant Congress
Expanding the Limits of the Expanded Criteria Donor
Nephrology Division, Hospital do Rim e Hipertensão, Sao Paulo, Brazil
Background: Use of grafts from expanded criteria donors (ECD) has increased significantly in recent years. Acceptable reported outcomes may increase the limits of acceptance and…2013 American Transplant Congress
Risk Factors in Venous Thrombosis of Renal Grafts from Deceased Non Heart-Beating Donors
Nephrology, Hospital 12 Octubre, Madrid, Spain
Background: The deceased donor kidney transplant to non heart-beating may have a higher rate of venous thrombosis (VT).The aim of this study is to analyze…2013 American Transplant Congress
Encapsulated Human Mesenchymal Stem Cells Reduce Alpha-Smooth Muscle Actin and Increase Matrix Metalloproteinase-9 Expression during Liver Fibrosis
INTRODUCTION: Mesenchymal stem cells (MSCs) transplantation has been suggested to be effective for the treatment of liver fibrosis, but the mechanisms of action are not…2013 American Transplant Congress
Practices and Attitudes toward Donor Pain Control in Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
Lahey Clinic; Northwestern U; U of Colorado
IntroductionClinicians at 9 A2ALL centers were surveyed about practices and attitudes toward pain control after donor hepatectomy.MethodsResponses were collected via Survey Monkey. A surgeon (S),…2013 American Transplant Congress
Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients
University of Alabama at Birmingham, Birmingham; Johns Hopkins University, Baltimore
Background: Kidney transplantation has been established as the therapy of choice for the treatment of end stage renal disease among appropriately selected HIV-infected (HIV+) individuals.…2013 American Transplant Congress
Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
ObjectiveTo examine tacrolimus (TAC) dose over time and by TAC trough levels in liver transplant (LTX) patients.MethodsA retrospective analysis of transplanted liver and a prescription…2013 American Transplant Congress
Evaluation of Immunocompetence in Tolerant Chimeric Recipients of Hematopoietic Stem Cell/Renal Transplants
We have established high levels of durable chimerism and immunosuppression-free graft survival without GVHD or engraftment syndrome in recipients of living donor facilitating cell/hematopoietic stem…2013 American Transplant Congress
Role of Graft Non-Hematopoietic Cells in Organ Transplant Tolerance, The
Success of organ transplantation currently depends on life-time immunosuppression, resulting in severe side effects. Induction of specific tolerance is ideal, which actually spontaneously occurs following…2013 American Transplant Congress
Potential Importance of 3 Year Surveillance Biopsies in Renal Transplantation
Most renal transplant surveillance biopsies [SBx] are taken within the first 12 months of transplantation and there is growing evidence that the detection of subclinical…
- « Previous Page
- 1
- …
- 72
- 73
- 74
- 75
- 76
- …
- 178
- Next Page »